Exelixis Inc (EXEL)
36.70
-0.14
(-0.38%)
USD |
NASDAQ |
Mar 28, 16:00
36.68
-0.02
(-0.05%)
After-Hours: 20:00
Exelixis Shareholders Equity (Quarterly): 2.244B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Halozyme Therapeutics Inc | 363.82M |
| Biomarin Pharmaceutical Inc | 5.658B |
| Catalyst Pharmaceuticals Inc | 727.63M |
| Incyte Corp | 3.448B |
| Blueprint Medicines Corp | 298.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.948B |
| Total Liabilities (Quarterly) | 703.49M |
| Current Ratio | 3.635 |